[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Small Molecule Chemical Drug CDMO Market Research Report 2024(Status and Outlook)

September 2024 | 164 pages | ID: GB98505E3A47EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

The development and production of small molecule chemical drugs usually involves many complex steps, and the synthesis and production of small molecule chemical drugs require specialized equipment and technology. CDMO (Contract Development and Manufacturing Organization) is an organization that provides outsourcing services to pharmaceutical companies. It can provide a range of services from drug development to production.

The global Small Molecule Chemical Drug CDMO market size was estimated at USD 47400 million in 2023 and is projected to reach USD 104786.30 million by 2030, exhibiting a CAGR of 12.00% during the forecast period.

North America Small Molecule Chemical Drug CDMO market size was USD 12351.09 million in 2023, at a CAGR of 10.29% during the forecast period of 2024 through 2030.

This report provides a deep insight into the global Small Molecule Chemical Drug CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Molecule Chemical Drug CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Molecule Chemical Drug CDMO market in any manner.

Global Small Molecule Chemical Drug CDMO Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Haixiang Pharmaceutical

Innovent Biologics

Betta Pharmaceuticals

Jiuzhou Pharmaceutical

Puluo Pharmaceutical

Menohua

Tianyu shares

Aoxiang Pharmaceutical

Hetero

CellMark

R&D Systems

Porton Pharmaceuticals

Kai Laiying

Smart Life

Notai Biotech

Aurobindo Pharma

Lonza Group

Catalent Inc.

Recipharm AB

Jubilant Pharmova Ltd

Patheon Inc. (Thermo Fisher Scientific Inc.)

Boehringer Ingelheim Group

Pfizer CentreSource

Baxter International Inc.

Market Segmentation (by Type)

Human Medicine

Veterinary Medicine

Market Segmentation (by Application)

Clinical Stage Projects

Commercialization Stage Projects

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Small Molecule Chemical Drug CDMO Market
  • Overview of the regional outlook of the Small Molecule Chemical Drug CDMO Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Chemical Drug CDMO Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Small Molecule Chemical Drug CDMO
1.2 Key Market Segments
  1.2.1 Small Molecule Chemical Drug CDMO Segment by Type
  1.2.2 Small Molecule Chemical Drug CDMO Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SMALL MOLECULE CHEMICAL DRUG CDMO MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Small Molecule Chemical Drug CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Small Molecule Chemical Drug CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SMALL MOLECULE CHEMICAL DRUG CDMO MARKET COMPETITIVE LANDSCAPE

3.1 Global Small Molecule Chemical Drug CDMO Sales by Manufacturers (2019-2024)
3.2 Global Small Molecule Chemical Drug CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Small Molecule Chemical Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Small Molecule Chemical Drug CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Small Molecule Chemical Drug CDMO Sales Sites, Area Served, Product Type
3.6 Small Molecule Chemical Drug CDMO Market Competitive Situation and Trends
  3.6.1 Small Molecule Chemical Drug CDMO Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Small Molecule Chemical Drug CDMO Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 SMALL MOLECULE CHEMICAL DRUG CDMO INDUSTRY CHAIN ANALYSIS

4.1 Small Molecule Chemical Drug CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE CHEMICAL DRUG CDMO MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Chemical Drug CDMO Sales Market Share by Type (2019-2024)
6.3 Global Small Molecule Chemical Drug CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Small Molecule Chemical Drug CDMO Price by Type (2019-2024)

7 SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Chemical Drug CDMO Market Sales by Application (2019-2024)
7.3 Global Small Molecule Chemical Drug CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Small Molecule Chemical Drug CDMO Sales Growth Rate by Application (2019-2024)

8 SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SEGMENTATION BY REGION

8.1 Global Small Molecule Chemical Drug CDMO Sales by Region
  8.1.1 Global Small Molecule Chemical Drug CDMO Sales by Region
  8.1.2 Global Small Molecule Chemical Drug CDMO Sales Market Share by Region
8.2 North America
  8.2.1 North America Small Molecule Chemical Drug CDMO Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Small Molecule Chemical Drug CDMO Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Small Molecule Chemical Drug CDMO Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Small Molecule Chemical Drug CDMO Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Small Molecule Chemical Drug CDMO Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Haixiang Pharmaceutical
  9.1.1 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
  9.1.2 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
  9.1.3 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Market Performance
  9.1.4 Haixiang Pharmaceutical Business Overview
  9.1.5 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO SWOT Analysis
  9.1.6 Haixiang Pharmaceutical Recent Developments
9.2 Innovent Biologics
  9.2.1 Innovent Biologics Small Molecule Chemical Drug CDMO Basic Information
  9.2.2 Innovent Biologics Small Molecule Chemical Drug CDMO Product Overview
  9.2.3 Innovent Biologics Small Molecule Chemical Drug CDMO Product Market Performance
  9.2.4 Innovent Biologics Business Overview
  9.2.5 Innovent Biologics Small Molecule Chemical Drug CDMO SWOT Analysis
  9.2.6 Innovent Biologics Recent Developments
9.3 Betta Pharmaceuticals
  9.3.1 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Basic Information
  9.3.2 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product Overview
  9.3.3 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product Market Performance
  9.3.4 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO SWOT Analysis
  9.3.5 Betta Pharmaceuticals Business Overview
  9.3.6 Betta Pharmaceuticals Recent Developments
9.4 Jiuzhou Pharmaceutical
  9.4.1 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
  9.4.2 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
  9.4.3 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product Market Performance
  9.4.4 Jiuzhou Pharmaceutical Business Overview
  9.4.5 Jiuzhou Pharmaceutical Recent Developments
9.5 Puluo Pharmaceutical
  9.5.1 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
  9.5.2 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
  9.5.3 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product Market Performance
  9.5.4 Puluo Pharmaceutical Business Overview
  9.5.5 Puluo Pharmaceutical Recent Developments
9.6 Menohua
  9.6.1 Menohua Small Molecule Chemical Drug CDMO Basic Information
  9.6.2 Menohua Small Molecule Chemical Drug CDMO Product Overview
  9.6.3 Menohua Small Molecule Chemical Drug CDMO Product Market Performance
  9.6.4 Menohua Business Overview
  9.6.5 Menohua Recent Developments
9.7 Tianyu shares
  9.7.1 Tianyu shares Small Molecule Chemical Drug CDMO Basic Information
  9.7.2 Tianyu shares Small Molecule Chemical Drug CDMO Product Overview
  9.7.3 Tianyu shares Small Molecule Chemical Drug CDMO Product Market Performance
  9.7.4 Tianyu shares Business Overview
  9.7.5 Tianyu shares Recent Developments
9.8 Aoxiang Pharmaceutical
  9.8.1 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
  9.8.2 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
  9.8.3 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Market Performance
  9.8.4 Aoxiang Pharmaceutical Business Overview
  9.8.5 Aoxiang Pharmaceutical Recent Developments
9.9 Hetero
  9.9.1 Hetero Small Molecule Chemical Drug CDMO Basic Information
  9.9.2 Hetero Small Molecule Chemical Drug CDMO Product Overview
  9.9.3 Hetero Small Molecule Chemical Drug CDMO Product Market Performance
  9.9.4 Hetero Business Overview
  9.9.5 Hetero Recent Developments
9.10 CellMark
  9.10.1 CellMark Small Molecule Chemical Drug CDMO Basic Information
  9.10.2 CellMark Small Molecule Chemical Drug CDMO Product Overview
  9.10.3 CellMark Small Molecule Chemical Drug CDMO Product Market Performance
  9.10.4 CellMark Business Overview
  9.10.5 CellMark Recent Developments
9.11 RandD Systems
  9.11.1 RandD Systems Small Molecule Chemical Drug CDMO Basic Information
  9.11.2 RandD Systems Small Molecule Chemical Drug CDMO Product Overview
  9.11.3 RandD Systems Small Molecule Chemical Drug CDMO Product Market Performance
  9.11.4 RandD Systems Business Overview
  9.11.5 RandD Systems Recent Developments
9.12 Porton Pharmaceuticals
  9.12.1 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Basic Information
  9.12.2 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product Overview
  9.12.3 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product Market Performance
  9.12.4 Porton Pharmaceuticals Business Overview
  9.12.5 Porton Pharmaceuticals Recent Developments
9.13 Kai Laiying
  9.13.1 Kai Laiying Small Molecule Chemical Drug CDMO Basic Information
  9.13.2 Kai Laiying Small Molecule Chemical Drug CDMO Product Overview
  9.13.3 Kai Laiying Small Molecule Chemical Drug CDMO Product Market Performance
  9.13.4 Kai Laiying Business Overview
  9.13.5 Kai Laiying Recent Developments
9.14 Smart Life
  9.14.1 Smart Life Small Molecule Chemical Drug CDMO Basic Information
  9.14.2 Smart Life Small Molecule Chemical Drug CDMO Product Overview
  9.14.3 Smart Life Small Molecule Chemical Drug CDMO Product Market Performance
  9.14.4 Smart Life Business Overview
  9.14.5 Smart Life Recent Developments
9.15 Notai Biotech
  9.15.1 Notai Biotech Small Molecule Chemical Drug CDMO Basic Information
  9.15.2 Notai Biotech Small Molecule Chemical Drug CDMO Product Overview
  9.15.3 Notai Biotech Small Molecule Chemical Drug CDMO Product Market Performance
  9.15.4 Notai Biotech Business Overview
  9.15.5 Notai Biotech Recent Developments
9.16 Aurobindo Pharma
  9.16.1 Aurobindo Pharma Small Molecule Chemical Drug CDMO Basic Information
  9.16.2 Aurobindo Pharma Small Molecule Chemical Drug CDMO Product Overview
  9.16.3 Aurobindo Pharma Small Molecule Chemical Drug CDMO Product Market Performance
  9.16.4 Aurobindo Pharma Business Overview
  9.16.5 Aurobindo Pharma Recent Developments
9.17 Lonza Group
  9.17.1 Lonza Group Small Molecule Chemical Drug CDMO Basic Information
  9.17.2 Lonza Group Small Molecule Chemical Drug CDMO Product Overview
  9.17.3 Lonza Group Small Molecule Chemical Drug CDMO Product Market Performance
  9.17.4 Lonza Group Business Overview
  9.17.5 Lonza Group Recent Developments
9.18 Catalent Inc.
  9.18.1 Catalent Inc. Small Molecule Chemical Drug CDMO Basic Information
  9.18.2 Catalent Inc. Small Molecule Chemical Drug CDMO Product Overview
  9.18.3 Catalent Inc. Small Molecule Chemical Drug CDMO Product Market Performance
  9.18.4 Catalent Inc. Business Overview
  9.18.5 Catalent Inc. Recent Developments
9.19 Recipharm AB
  9.19.1 Recipharm AB Small Molecule Chemical Drug CDMO Basic Information
  9.19.2 Recipharm AB Small Molecule Chemical Drug CDMO Product Overview
  9.19.3 Recipharm AB Small Molecule Chemical Drug CDMO Product Market Performance
  9.19.4 Recipharm AB Business Overview
  9.19.5 Recipharm AB Recent Developments
9.20 Jubilant Pharmova Ltd
  9.20.1 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Basic Information
  9.20.2 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product Overview
  9.20.3 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product Market Performance
  9.20.4 Jubilant Pharmova Ltd Business Overview
  9.20.5 Jubilant Pharmova Ltd Recent Developments
9.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
  9.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Basic Information
  9.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product Overview
  9.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product Market Performance
  9.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
  9.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Developments
9.22 Boehringer Ingelheim Group
  9.22.1 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Basic Information
  9.22.2 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product Overview
  9.22.3 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product Market Performance
  9.22.4 Boehringer Ingelheim Group Business Overview
  9.22.5 Boehringer Ingelheim Group Recent Developments
9.23 Pfizer CentreSource
  9.23.1 Pfizer CentreSource Small Molecule Chemical Drug CDMO Basic Information
  9.23.2 Pfizer CentreSource Small Molecule Chemical Drug CDMO Product Overview
  9.23.3 Pfizer CentreSource Small Molecule Chemical Drug CDMO Product Market Performance
  9.23.4 Pfizer CentreSource Business Overview
  9.23.5 Pfizer CentreSource Recent Developments
9.24 Baxter International Inc.
  9.24.1 Baxter International Inc. Small Molecule Chemical Drug CDMO Basic Information
  9.24.2 Baxter International Inc. Small Molecule Chemical Drug CDMO Product Overview
  9.24.3 Baxter International Inc. Small Molecule Chemical Drug CDMO Product Market Performance
  9.24.4 Baxter International Inc. Business Overview
  9.24.5 Baxter International Inc. Recent Developments

10 SMALL MOLECULE CHEMICAL DRUG CDMO MARKET FORECAST BY REGION

10.1 Global Small Molecule Chemical Drug CDMO Market Size Forecast
10.2 Global Small Molecule Chemical Drug CDMO Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Small Molecule Chemical Drug CDMO Market Size Forecast by Country
  10.2.3 Asia Pacific Small Molecule Chemical Drug CDMO Market Size Forecast by Region
  10.2.4 South America Small Molecule Chemical Drug CDMO Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Small Molecule Chemical Drug CDMO by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Small Molecule Chemical Drug CDMO Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Small Molecule Chemical Drug CDMO by Type (2025-2030)
  11.1.2 Global Small Molecule Chemical Drug CDMO Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Small Molecule Chemical Drug CDMO by Type (2025-2030)
11.2 Global Small Molecule Chemical Drug CDMO Market Forecast by Application (2025-2030)
  11.2.1 Global Small Molecule Chemical Drug CDMO Sales (K Units) Forecast by Application
  11.2.2 Global Small Molecule Chemical Drug CDMO Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Chemical Drug CDMO Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Chemical Drug CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Small Molecule Chemical Drug CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Small Molecule Chemical Drug CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Small Molecule Chemical Drug CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Chemical Drug CDMO as of 2022)
Table 10. Global Market Small Molecule Chemical Drug CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Small Molecule Chemical Drug CDMO Sales Sites and Area Served
Table 12. Manufacturers Small Molecule Chemical Drug CDMO Product Type
Table 13. Global Small Molecule Chemical Drug CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Small Molecule Chemical Drug CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Molecule Chemical Drug CDMO Market Challenges
Table 22. Global Small Molecule Chemical Drug CDMO Sales by Type (K Units)
Table 23. Global Small Molecule Chemical Drug CDMO Market Size by Type (M USD)
Table 24. Global Small Molecule Chemical Drug CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Small Molecule Chemical Drug CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Small Molecule Chemical Drug CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Small Molecule Chemical Drug CDMO Market Size Share by Type (2019-2024)
Table 28. Global Small Molecule Chemical Drug CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Small Molecule Chemical Drug CDMO Sales (K Units) by Application
Table 30. Global Small Molecule Chemical Drug CDMO Market Size by Application
Table 31. Global Small Molecule Chemical Drug CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Small Molecule Chemical Drug CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Small Molecule Chemical Drug CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Small Molecule Chemical Drug CDMO Market Share by Application (2019-2024)
Table 35. Global Small Molecule Chemical Drug CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Small Molecule Chemical Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Small Molecule Chemical Drug CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Small Molecule Chemical Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Small Molecule Chemical Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Small Molecule Chemical Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Small Molecule Chemical Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Small Molecule Chemical Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
Table 44. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
Table 45. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Haixiang Pharmaceutical Business Overview
Table 47. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO SWOT Analysis
Table 48. Haixiang Pharmaceutical Recent Developments
Table 49. Innovent Biologics Small Molecule Chemical Drug CDMO Basic Information
Table 50. Innovent Biologics Small Molecule Chemical Drug CDMO Product Overview
Table 51. Innovent Biologics Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Innovent Biologics Business Overview
Table 53. Innovent Biologics Small Molecule Chemical Drug CDMO SWOT Analysis
Table 54. Innovent Biologics Recent Developments
Table 55. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Basic Information
Table 56. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product Overview
Table 57. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO SWOT Analysis
Table 59. Betta Pharmaceuticals Business Overview
Table 60. Betta Pharmaceuticals Recent Developments
Table 61. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
Table 62. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
Table 63. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Jiuzhou Pharmaceutical Business Overview
Table 65. Jiuzhou Pharmaceutical Recent Developments
Table 66. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
Table 67. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
Table 68. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Puluo Pharmaceutical Business Overview
Table 70. Puluo Pharmaceutical Recent Developments
Table 71. Menohua Small Molecule Chemical Drug CDMO Basic Information
Table 72. Menohua Small Molecule Chemical Drug CDMO Product Overview
Table 73. Menohua Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Menohua Business Overview
Table 75. Menohua Recent Developments
Table 76. Tianyu shares Small Molecule Chemical Drug CDMO Basic Information
Table 77. Tianyu shares Small Molecule Chemical Drug CDMO Product Overview
Table 78. Tianyu shares Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Tianyu shares Business Overview
Table 80. Tianyu shares Recent Developments
Table 81. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Basic Information
Table 82. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Overview
Table 83. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Aoxiang Pharmaceutical Business Overview
Table 85. Aoxiang Pharmaceutical Recent Developments
Table 86. Hetero Small Molecule Chemical Drug CDMO Basic Information
Table 87. Hetero Small Molecule Chemical Drug CDMO Product Overview
Table 88. Hetero Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Hetero Business Overview
Table 90. Hetero Recent Developments
Table 91. CellMark Small Molecule Chemical Drug CDMO Basic Information
Table 92. CellMark Small Molecule Chemical Drug CDMO Product Overview
Table 93. CellMark Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. CellMark Business Overview
Table 95. CellMark Recent Developments
Table 96. RandD Systems Small Molecule Chemical Drug CDMO Basic Information
Table 97. RandD Systems Small Molecule Chemical Drug CDMO Product Overview
Table 98. RandD Systems Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. RandD Systems Business Overview
Table 100. RandD Systems Recent Developments
Table 101. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Basic Information
Table 102. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product Overview
Table 103. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Porton Pharmaceuticals Business Overview
Table 105. Porton Pharmaceuticals Recent Developments
Table 106. Kai Laiying Small Molecule Chemical Drug CDMO Basic Information
Table 107. Kai Laiying Small Molecule Chemical Drug CDMO Product Overview
Table 108. Kai Laiying Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Kai Laiying Business Overview
Table 110. Kai Laiying Recent Developments
Table 111. Smart Life Small Molecule Chemical Drug CDMO Basic Information
Table 112. Smart Life Small Molecule Chemical Drug CDMO Product Overview
Table 113. Smart Life Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Smart Life Business Overview
Table 115. Smart Life Recent Developments
Table 116. Notai Biotech Small Molecule Chemical Drug CDMO Basic Information
Table 117. Notai Biotech Small Molecule Chemical Drug CDMO Product Overview
Table 118. Notai Biotech Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Notai Biotech Business Overview
Table 120. Notai Biotech Recent Developments
Table 121. Aurobindo Pharma Small Molecule Chemical Drug CDMO Basic Information
Table 122. Aurobindo Pharma Small Molecule Chemical Drug CDMO Product Overview
Table 123. Aurobindo Pharma Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Aurobindo Pharma Business Overview
Table 125. Aurobindo Pharma Recent Developments
Table 126. Lonza Group Small Molecule Chemical Drug CDMO Basic Information
Table 127. Lonza Group Small Molecule Chemical Drug CDMO Product Overview
Table 128. Lonza Group Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Lonza Group Business Overview
Table 130. Lonza Group Recent Developments
Table 131. Catalent Inc. Small Molecule Chemical Drug CDMO Basic Information
Table 132. Catalent Inc. Small Molecule Chemical Drug CDMO Product Overview
Table 133. Catalent Inc. Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Catalent Inc. Business Overview
Table 135. Catalent Inc. Recent Developments
Table 136. Recipharm AB Small Molecule Chemical Drug CDMO Basic Information
Table 137. Recipharm AB Small Molecule Chemical Drug CDMO Product Overview
Table 138. Recipharm AB Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Recipharm AB Business Overview
Table 140. Recipharm AB Recent Developments
Table 141. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Basic Information
Table 142. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product Overview
Table 143. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Jubilant Pharmova Ltd Business Overview
Table 145. Jubilant Pharmova Ltd Recent Developments
Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Basic Information
Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product Overview
Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
Table 150. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Developments
Table 151. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Basic Information
Table 152. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product Overview
Table 153. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Boehringer Ingelheim Group Business Overview
Table 155. Boehringer Ingelheim Group Recent Developments
Table 156. Pfizer CentreSource Small Molecule Chemical Drug CDMO Basic Information
Table 157. Pfizer CentreSource Small Molecule Chemical Drug CDMO Product Overview
Table 158. Pfizer CentreSource Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Pfizer CentreSource Business Overview
Table 160. Pfizer CentreSource Recent Developments
Table 161. Baxter International Inc. Small Molecule Chemical Drug CDMO Basic Information
Table 162. Baxter International Inc. Small Molecule Chemical Drug CDMO Product Overview
Table 163. Baxter International Inc. Small Molecule Chemical Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Baxter International Inc. Business Overview
Table 165. Baxter International Inc. Recent Developments
Table 166. Global Small Molecule Chemical Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 167. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 168. North America Small Molecule Chemical Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 169. North America Small Molecule Chemical Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 170. Europe Small Molecule Chemical Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 171. Europe Small Molecule Chemical Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 172. Asia Pacific Small Molecule Chemical Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 173. Asia Pacific Small Molecule Chemical Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 174. South America Small Molecule Chemical Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 175. South America Small Molecule Chemical Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 176. Middle East and Africa Small Molecule Chemical Drug CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 177. Middle East and Africa Small Molecule Chemical Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 178. Global Small Molecule Chemical Drug CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 179. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 180. Global Small Molecule Chemical Drug CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 181. Global Small Molecule Chemical Drug CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 182. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Small Molecule Chemical Drug CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Chemical Drug CDMO Market Size (M USD), 2019-2030
Figure 5. Global Small Molecule Chemical Drug CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Small Molecule Chemical Drug CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Chemical Drug CDMO Market Size by Country (M USD)
Figure 11. Small Molecule Chemical Drug CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Small Molecule Chemical Drug CDMO Revenue Share by Manufacturers in 2023
Figure 13. Small Molecule Chemical Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Small Molecule Chemical Drug CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Small Molecule Chemical Drug CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Small Molecule Chemical Drug CDMO Market Share by Type
Figure 18. Sales Market Share of Small Molecule Chemical Drug CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Small Molecule Chemical Drug CDMO by Type in 2023
Figure 20. Market Size Share of Small Molecule Chemical Drug CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Small Molecule Chemical Drug CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Small Molecule Chemical Drug CDMO Market Share by Application
Figure 24. Global Small Molecule Chemical Drug CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Small Molecule Chemical Drug CDMO Sales Market Share by Application in 2023
Figure 26. Global Small Molecule Chemical Drug CDMO Market Share by Application (2019-2024)
Figure 27. Global Small Molecule Chemical Drug CDMO Market Share by Application in 2023
Figure 28. Global Small Molecule Chemical Drug CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Small Molecule Chemical Drug CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Small Molecule Chemical Drug CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Small Molecule Chemical Drug CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Small Molecule Chemical Drug CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Small Molecule Chemical Drug CDMO Sales Market Share by Country in 2023
Figure 37. Germany Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Small Molecule Chemical Drug CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Small Molecule Chemical Drug CDMO Sales Market Share by Region in 2023
Figure 44. China Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Small Molecule Chemical Drug CDMO Sales and Growth Rate (K Units)
Figure 50. South America Small Molecule Chemical Drug CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Small Molecule Chemical Drug CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Small Molecule Chemical Drug CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Small Molecule Chemical Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Small Molecule Chemical Drug CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Small Molecule Chemical Drug CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Small Molecule Chemical Drug CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Small Molecule Chemical Drug CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Small Molecule Chemical Drug CDMO Market Share Forecast by Application (2025-2030)


More Publications